These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 20513332)

  • 1. Assessment of the mixing efficiency of neutral protamine Hagedorn cartridges.
    Kaiser P; Maxeiner S; Weise A; Nolden F; Borck A; Forst T; Pfützner A
    J Diabetes Sci Technol; 2010 May; 4(3):652-7. PubMed ID: 20513332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An analysis of the mixing efficiency of neutral protamine Hagedorn cartridges.
    Monte SV; Comerford P; Dearing N
    J Diabetes Sci Technol; 2010 May; 4(3):658-60. PubMed ID: 20513333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different insulin concentrations in resuspended vs. unsuspended NPH insulin: Practical aspects of subcutaneous injection in patients with diabetes.
    Lucidi P; Porcellati F; Marinelli Andreoli A; Candeloro P; Cioli P; Bolli GB; Fanelli CG
    Diabetes Metab; 2018 Sep; 44(4):368-372. PubMed ID: 28599764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inadequate suspension of neutral protamine Hagendorn (NPH) insulin in pens.
    Jehle PM; Micheler C; Jehle DR; Breitig D; Boehm BO
    Lancet; 1999 Nov; 354(9190):1604-7. PubMed ID: 10560676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Daily insulin doses and injection frequencies of neutral protamine hagedorn (NPH) insulin, insulin detemir and insulin glargine in type 1 and type 2 diabetes: a multicenter analysis of 51 964 patients from the German/Austrian DPV-wiss database.
    Laubner K; Molz K; Kerner W; Karges W; Lang W; Dapp A; Schütt M; Best F; Seufert J; Holl RW
    Diabetes Metab Res Rev; 2014 Jul; 30(5):395-404. PubMed ID: 24302583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and Pharmacodynamics of NPH Insulin in Type 1 Diabetes: The Importance of Appropriate Resuspension Before Subcutaneous Injection.
    Lucidi P; Porcellati F; Marinelli Andreoli A; Carriero I; Candeloro P; Cioli P; Bolli GB; Fanelli CG
    Diabetes Care; 2015 Dec; 38(12):2204-10. PubMed ID: 26358287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of bedtime insulin glargine with bedtime neutral protamine hagedorn insulin in patients with type 2 diabetes: subgroup analysis of patients taking once-daily insulin in a multicenter, randomized, parallel group study.
    Fonseca V; Bell DS; Berger S; Thomson S; Mecca TE
    Am J Med Sci; 2004 Nov; 328(5):274-80. PubMed ID: 15545844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nocturnal glucose metabolism after bedtime injection of insulin glargine or neutral protamine hagedorn insulin in patients with type 2 diabetes.
    Linn T; Fischer B; Soydan N; Eckhard M; Ehl J; Kunz C; Bretzel RG
    J Clin Endocrinol Metab; 2008 Oct; 93(10):3839-46. PubMed ID: 18611975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Administration of neutral protamine Hagedorn insulin at bedtime versus with dinner in type 1 diabetes mellitus to avoid nocturnal hypoglycemia and improve control. A randomized, controlled trial.
    Fanelli CG; Pampanelli S; Porcellati F; Rossetti P; Brunetti P; Bolli GB
    Ann Intern Med; 2002 Apr; 136(7):504-14. PubMed ID: 11926785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glimepiride combined with morning insulin glargine, bedtime neutral protamine hagedorn insulin, or bedtime insulin glargine in patients with type 2 diabetes. A randomized, controlled trial.
    Fritsche A; Schweitzer MA; Häring HU;
    Ann Intern Med; 2003 Jun; 138(12):952-9. PubMed ID: 12809451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of QD insulin detemir or neutral protamine Hagedorn on blood glucose control in patients with type I diabetes mellitus using a basal-bolus regimen.
    Russell-Jones D; Simpson R; Hylleberg B; Draeger E; Bolinder J
    Clin Ther; 2004 May; 26(5):724-36. PubMed ID: 15220016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose-dependent subcutaneous absorption of porcine, bovine and human NPH insulins.
    Hildebrandt P; Birch K; Sestoft L; Vølund A
    Acta Med Scand; 1984; 215(1):69-73. PubMed ID: 6364700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is insulin diluted when stored in water?
    Plager P; Nurie K; Omann T; Moran A; Piloya T; Bahendeka S; Sunni M
    Pediatr Diabetes; 2017 May; 18(3):237-240. PubMed ID: 26826013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of inpatient insulin regimens with detemir plus aspart versus neutral protamine hagedorn plus regular in medical patients with type 2 diabetes.
    Umpierrez GE; Hor T; Smiley D; Temponi A; Umpierrez D; Ceron M; Munoz C; Newton C; Peng L; Baldwin D
    J Clin Endocrinol Metab; 2009 Feb; 94(2):564-9. PubMed ID: 19017758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term efficacy and safety of insulin detemir compared to Neutral Protamine Hagedorn insulin in patients with Type 1 diabetes using a treat-to-target basal-bolus regimen with insulin aspart at meals: a 2-year, randomized, controlled trial.
    Bartley PC; Bogoev M; Larsen J; Philotheou A
    Diabet Med; 2008 Apr; 25(4):442-9. PubMed ID: 18387078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Similar progression of diabetic retinopathy with insulin glargine and neutral protamine Hagedorn (NPH) insulin in patients with type 2 diabetes: a long-term, randomised, open-label study.
    Rosenstock J; Fonseca V; McGill JB; Riddle M; Hallé JP; Hramiak I; Johnston P; Davis M
    Diabetologia; 2009 Sep; 52(9):1778-88. PubMed ID: 19526210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunologic analysis of anaphylaxis to protamine component in neutral protamine Hagedorn human insulin.
    Dykewicz MS; Kim HW; Orfan N; Yoo TJ; Lieberman P
    J Allergy Clin Immunol; 1994 Jan; 93(1 Pt 1):117-25. PubMed ID: 8308177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of safety and efficacy of insulin glargine and neutral protamine hagedorn insulin in older adults with type 2 diabetes mellitus: results from a pooled analysis.
    Lee P; Chang A; Blaum C; Vlajnic A; Gao L; Halter J
    J Am Geriatr Soc; 2012 Jan; 60(1):51-9. PubMed ID: 22239291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time-action profile of an oral enteric insulin formulation in healthy Chinese volunteers.
    Li J; Wang Y; Han L; Sun X; Yu H; Yu Y
    Clin Ther; 2012 Dec; 34(12):2333-8. PubMed ID: 23195963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the dose accuracy of prefilled insulin pens.
    Weise A; Pfützner JW; Borig J; Pfützner AM; Safinowski M; Hänel H; Musholt PB; Pfützner A
    J Diabetes Sci Technol; 2009 Jan; 3(1):149-53. PubMed ID: 20046658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.